238 related articles for article (PubMed ID: 23330353)
1. Adult medulloblastoma, from spongioblastoma cerebelli to the present day: a review of treatment and the integration of molecular markers.
Shonka N; Brandes A; De Groot JF
Oncology (Williston Park); 2012 Nov; 26(11):1083-91. PubMed ID: 23330353
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
Terterov S; Krieger MD; Bowen I; McComb JG
J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
[TBL] [Abstract][Full Text] [Related]
3. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
4. The tumor biology and molecular characteristics of medulloblastoma identifying prognostic factors associated with survival outcomes and prognosis.
Kim W; Choy W; Dye J; Nagasawa D; Safaee M; Fong B; Yang I
J Clin Neurosci; 2011 Jul; 18(7):886-90. PubMed ID: 21640908
[TBL] [Abstract][Full Text] [Related]
5. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).
Brandes AA; Franceschi E; Tosoni A; Reni M; Gatta G; Vecht C; Kortmann RD
Crit Rev Oncol Hematol; 2009 Aug; 71(2):165-79. PubMed ID: 19303318
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
7. Clinical management of medulloblastoma in adults.
Eisenstat DD
Expert Rev Anticancer Ther; 2004 Oct; 4(5):795-802. PubMed ID: 15485314
[TBL] [Abstract][Full Text] [Related]
8. Relapse patterns in pediatric embryonal central nervous system tumors.
Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Yeom K; Vogel H; Fisher PG; Partap S
J Neurooncol; 2013 Nov; 115(2):209-15. PubMed ID: 23921420
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse.
Chargari C; Feuvret L; Levy A; Lamproglou I; Assouline A; Hemery C; Ghorbal L; Lopez S; Tep B; G GB; Lang P; Laigle-Donadey F; Cornu P; Mazeron JJ; Simon JM
Br J Neurosurg; 2010 Aug; 24(4):460-7. PubMed ID: 20726753
[TBL] [Abstract][Full Text] [Related]
10. Review of the prognostic factors in medulloblastoma of children and adults.
Brandes AA; Paris MK
Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661
[TBL] [Abstract][Full Text] [Related]
11. Updates on Management of Adult Medulloblastoma.
Majd N; Penas-Prado M
Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
[TBL] [Abstract][Full Text] [Related]
12. A tale of two tumors: pediatric and adult medulloblastoma.
Aizer AA; Chan AW
Oncology (Williston Park); 2012 Nov; 26(11):1095-7. PubMed ID: 23330354
[No Abstract] [Full Text] [Related]
13. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. The effect of patients' age and extent of disease on prognosis.
Allen JC; Epstein F
J Neurosurg; 1982 Oct; 57(4):446-51. PubMed ID: 7108593
[No Abstract] [Full Text] [Related]
16. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
[TBL] [Abstract][Full Text] [Related]
17. Current multimodality management of medulloblastoma.
Paulino AC
Curr Probl Cancer; 2002; 26(6):317-56. PubMed ID: 12447347
[No Abstract] [Full Text] [Related]
18. [Medulloblastoma of the cerebellum. Apropos of 120 cases from 1953 to 1982].
Baranzelli MC; Demaille MC; Dhellemmes P; Madelain M; Nuyts JP
Ann Pediatr (Paris); 1986 Feb; 33(2):93-8. PubMed ID: 3963719
[No Abstract] [Full Text] [Related]
19. Medulloblastoma: molecular classifications and prognostic associations.
Shrieve DC; Colman H
Oncology (Williston Park); 2012 Nov; 26(11):1097, 1102. PubMed ID: 23330355
[No Abstract] [Full Text] [Related]
20. Characteristics and outcomes of medulloblastoma in adults.
Ang C; Hauerstock D; Guiot MC; Kasymjanova G; Roberge D; Kavan P; Muanza T
Pediatr Blood Cancer; 2008 Nov; 51(5):603-7. PubMed ID: 18649371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]